Guidance
Evidence-based recommendations on multiplex allergen testing, using ImmunoCAP ISAC 112 in people with allergy that is difficult to diagnose.
Is this guidance up to date?
We reviewed the evidence in September 2020. We found nothing new that affects the recommendations in this guidance.
Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.
Guidance development process
How we develop diagnostics guidance
This guidance was previously called ImmunoCAP ISAC 112 and Microtest for multiplex allergen testing.